Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Victoire De Castelbajac"'
Autor:
Alice Hours, Aullene Toussaint, Victoire De Castelbajac, Camille Sautter, Julie Borghese, Sophie Frank, Florence Coussy, Enora Laas, Beatriz Grandal, Elise Dumas, Eric Daoud, Julien Guerin, Thomas Balezeau, Jean-Guillaume Feron, Virginie Fourchotte, Youlia Kirova, Florence Lerebours, Jean-Yves Pierga, Eugénie Guillot, Pietro Santulli, Michael Grynberg, Charlotte Sonigo, Emmanuel Reyrat, Pauline Soibinet-Oudot, Fabien Reyal, Anne-Sophie Hamy
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeFemale breast cancer (BC) patients exposed to gonadotoxic chemotherapy are at risk of future infertility. There is evidence of disparities in the discussion of fertility preservation for these patients. The aim of the study was to identify fac
Externí odkaz:
https://doaj.org/article/2dc89f2c08df4228aada40785680bc20
Autor:
Victoire de Castelbajac
Publikováno v:
Sages-Femmes. 20:23-26
Le recours aux techniques de preservation de la fertilite lors d’un diagnostic de cancer, notamment en cas de chimiotherapie fortement gonadotoxique, permet aux couples de conserver un projet d’enfant. L’information, la reassurance et la reeval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::706e8caadc0b8a23d2c7d55ae1c6e9d8
https://doi.org/10.1016/j.sagf.2021.05.007
https://doi.org/10.1016/j.sagf.2021.05.007
Autor:
Mathias Fehr, Jean-Damien Combes, Thibaut Reverdy, Olivier Tredan, Thibault De La Motte Rouge, S. Intidhar Labidi-Galy, Victoire de Castelbajac, Olfa Derbel, Lisa Golmard, Ketty Heimgartner-Hu, Pierre-Etienne Heudel, Valérie Bonadona, Valeria Viassolo, Manuel Rodrigues, Isabelle Ray-Coquard, Louise Crivelli, Hemerson Guevara, Anita Wolfer, Pauline Vaflard, Adrien Buisson, Fernando Bazan, Timothée Olivier, Elsa Kalbacher, Viola Heinzelmann-Schwarz
Publikováno v:
Translational Cancer Research
Objective To investigate clinical factors associated with prolonged progression-free survival (PFS) and overall survival (OS) in relapsing epithelial ovarian cancer (EOC) patients with BRCA mutations and receiving olaparib as maintenance therapy in d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c531e69f1bf8c1d2d9c2d879b06ac8
https://pubmed.ncbi.nlm.nih.gov/35117386
https://pubmed.ncbi.nlm.nih.gov/35117386
Autor:
Adrien Buisson, Fernando Bazan, Timothée Olivier, Olivier Tredan, Valérie Bonadona, Elsa Kalbacher, Hemerson Guevara, Anita Wolfer, Ketty Hu, Jean-Damien Combes, Lisa Golmard, Victoire de Castelbajac, Thibault De La Motte Rouge, Sana Intidhar Labidi-Galy, Olfa Derbel, Valeria Viassolo, Manuel Rodrigues, Isabelle Ray-Coquard, Pauline Vaflard, Louise Crivelli
Publikováno v:
Journal of Clinical Oncology. 36:5558-5558
5558Background: To investigate clinical factors predictive for prolonged progression-free survival (PFS) in ovarian cancer (OC) patients carrying BRCA mutations and receiving olaparib as a maintena...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1ad3a2a8a30bdd7aca9561d2e74e9f9
https://doi.org/10.1200/jco.2018.36.15_suppl.5558
https://doi.org/10.1200/jco.2018.36.15_suppl.5558